Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing.
Life sciences firm Analytik Jena AG has acquired all of the assets of insolvent molecular diagnostics firm SIRS-Lab GMBH for an undisclosed amount. (May)
Analytik Jena gets various molecular diagnostics for infections, 50 patents, and 10 employees. Thirteen-year-old SIRS-Lab, which is also based in...